Drugs Made In America Acquisition II Corp. Ordinary Shares
DMII | NASDAQ
$10.20
$0.00 (0.00%)
At close: Oct 30, 2026, 3:59 PM ET
$10.19
-$0.01 (-0.10%)
After-hours:
Oct 30, 2026, 4:02 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 |
|---|---|---|
Cash & Equivalents | 223 | 17.04K |
Short-Term Investments | n/a | n/a |
Long-Term Investments | 504.93M | n/a |
Other Long-Term Assets | n/a | 78.45K |
Receivables | n/a | n/a |
Inventory | n/a | n/a |
Other Current Assets | n/a | n/a |
Total Current Assets | 26.04K | 59.62K |
Property-Plant & Equipment | n/a | n/a |
Goodwill & Intangibles | n/a | n/a |
Total Long-Term Assets | 504.93M | 78.45K |
Total Assets | 504.96M | 138.06K |
Account Payables | 99.36K | n/a |
Deferred Revenue | n/a | n/a |
Short-Term Debt | n/a | 250.1K |
Other Current Liabilities | 201.51K | n/a |
Total Current Liabilities | 300.86K | 254.78K |
Long-Term Debt | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a |
Total Long-Term Liabilities | 17.5M | n/a |
Total Liabilities | 17.8M | 254.78K |
Total Debt | n/a | 250.1K |
Book Value | 487.16M | -116.72K |
Book Value Per Share | 36.66 | 0 |
Common Stock | 504.94M | 1.44K |
Retained Earnings | -17.78M | -151.72K |
Comprehensive Income | n/a | n/a |
Shareholders Equity | 487.16M | -116.72K |
Total Investments | 504.93M | n/a |
Add to Watchlist
Select watchlists to add or remove DMII